198 related articles for article (PubMed ID: 29895015)
1. Frequent and Rare HABP2 Variants Are Not Associated with Increased Susceptibility to Familial Nonmedullary Thyroid Carcinoma in the Spanish Population.
de Randamie R; Martos-Moreno GÁ; Lumbreras C; Chueca M; Donnay S; Luque M; Regojo RM; Mendiola M; Hardisson D; Argente J; Moreno JC
Horm Res Paediatr; 2018; 89(6):397-407. PubMed ID: 29895015
[TBL] [Abstract][Full Text] [Related]
2. HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.
Zhang T; Xing M
J Natl Cancer Inst; 2016 Jun; 108(6):djv415. PubMed ID: 26832773
[TBL] [Abstract][Full Text] [Related]
3. HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.
Weeks AL; Wilson SG; Ward L; Goldblatt J; Hui J; Walsh JP
BMC Med Genet; 2016 Aug; 17(1):60. PubMed ID: 27530615
[TBL] [Abstract][Full Text] [Related]
4. Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review.
Colombo C; Muzza M; Proverbio MC; Ercoli G; Perrino M; Cirello V; Vicentini L; Ferrero S; Fugazzola L
Clin Endocrinol (Oxf); 2017 Jun; 86(6):837-844. PubMed ID: 28222214
[TBL] [Abstract][Full Text] [Related]
5. Letter regarding the article: "Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls" by Kern et al.
Colombo C; Fugazzola L; Muzza M; Proverbio MC; Cirello V
Eur J Med Genet; 2018 Feb; 61(2):104-105. PubMed ID: 28779995
[TBL] [Abstract][Full Text] [Related]
6. HABP2 G534E Variant in Papillary Thyroid Carcinoma.
Tomsic J; Fultz R; Liyanarachchi S; He H; Senter L; de la Chapelle A
PLoS One; 2016; 11(1):e0146315. PubMed ID: 26745718
[TBL] [Abstract][Full Text] [Related]
7. Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.
Gara SK; Jia L; Merino MJ; Agarwal SK; Zhang L; Cam M; Patel D; Kebebew E
N Engl J Med; 2015 Jul; 373(5):448-55. PubMed ID: 26222560
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.
Moses W; Weng J; Kebebew E
Thyroid; 2011 Apr; 21(4):367-71. PubMed ID: 21190444
[TBL] [Abstract][Full Text] [Related]
9. G534E Variant in HABP2 and Nonmedullary Thyroid Cancer.
Ruiz-Ferrer M; Fernández RM; Navarro E; Antiñolo G; Borrego S
Thyroid; 2016 Jul; 26(7):987-8. PubMed ID: 27245704
[No Abstract] [Full Text] [Related]
10. HABP2 Gene Mutations Do Not Cause Familial or Sporadic Non-Medullary Thyroid Cancer in a Highly Inbred Middle Eastern Population.
Alzahrani AS; Murugan AK; Qasem E; Al-Hindi H
Thyroid; 2016 May; 26(5):667-71. PubMed ID: 26906432
[TBL] [Abstract][Full Text] [Related]
11. HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.
Pinheiro M; Drigo SA; Tonhosolo R; Andrade SCS; Marchi FA; Jurisica I; Kowalski LP; Achatz MI; Rogatto SR
Oncotarget; 2017 Jun; 8(25):40896-40905. PubMed ID: 28402931
[TBL] [Abstract][Full Text] [Related]
12. Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas.
Marques IJ; Moura MM; Cabrera R; Pinto AE; Simões-Pereira J; Santos C; Menezes FD; Montezuma D; Henrique R; Rodrigues Teixeira M; Leite V; Cavaco BM
Clin Endocrinol (Oxf); 2017 Oct; 87(4):394-399. PubMed ID: 28502101
[TBL] [Abstract][Full Text] [Related]
13. HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series.
Cantara S; Marzocchi C; Castagna MG; Pacini F
J Endocrinol Invest; 2017 May; 40(5):557-560. PubMed ID: 27873212
[TBL] [Abstract][Full Text] [Related]
14. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations.
Cavaco BM; Batista PF; Martins C; Banito A; do Rosário F; Limbert E; Sobrinho LG; Leite V
Endocr Relat Cancer; 2008 Mar; 15(1):207-15. PubMed ID: 18310288
[TBL] [Abstract][Full Text] [Related]
15. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAF
Lee SE; Hwang TS; Choi YL; Kim WY; Han HS; Lim SD; Kim WS; Yoo YB; Kim SK
Thyroid; 2017 Jun; 27(6):802-810. PubMed ID: 28293988
[TBL] [Abstract][Full Text] [Related]
16. Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls.
Kern B; Coppin L; Romanet P; Crépin M; Szuster I; Renaud F; Leteurtre E; Frénois F; Wemeau JL; Carnaille B; Cardot-Bauters C; Do Cao C; Pigny P
Eur J Med Genet; 2017 Mar; 60(3):178-184. PubMed ID: 28089742
[TBL] [Abstract][Full Text] [Related]
17. RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.
Simeone P; Alberti S
J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27418631
[No Abstract] [Full Text] [Related]
18. RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.
Carvajal-Carmona LG; Tomlinson I; Sahasrabudhe R
J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27154966
[No Abstract] [Full Text] [Related]
19. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer.
Xing M
Clin Endocrinol (Oxf); 2005 Sep; 63(3):263-6. PubMed ID: 16117812
[TBL] [Abstract][Full Text] [Related]
20. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
